MPLT
MapLight Therapeutics, Inc.
$36.57
-2.75 (-6.99%)
At close · Jul 13
Market Cap
$1.66B
Shares
45,345,676
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$161.15M
-107.7%
FY2025
Diluted EPS
-$18.56
+82.4%
FY2025
Operating Cash Flow
-$138.14M
-75.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 |
|---|---|---|---|
| — | $138.35M | $68.52M | |
| — | $30.73M | $14.42M | |
| — | $169.08M | $82.95M | |
| — | -$169.08M | -$82.95M | |
| — | $5.52M | $4.5M | |
| — | $7.93M | $5.37M | |
| -$199.48M | -$161.15M | -$77.58M | |
| — | -$161.54M | -$77.42M | |
| USD/shares | — | -$18.56 | -$105.38 |
| USD/shares | — | -$18.56 | -$105.38 |
| shares | — | 8.68M | 736.18K |
| shares | — | 8.68M | 736.18K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.